I personally think BM might be quite happy to take them all - after all he is a director and knows the business quite intimately. He probably gets a bit of a sub underwriting fee too.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025